MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.gastrohep.2020.10.004

Медицинская библиотека · Gastroenterologia y hepatologia · 2020

Optimization of azathioprine dose in combined treatment with anti-TNF-alpha in inflammatory bowel disease.

Lucas Ramos Javier, Suárez Ferrer Cristina, Poza Cordón Joaquín, Sánchez Azofra María, Rueda García Jose Luis, Martin Arranz Eduardo, Yebra Carmona Jorge, Andaluz García Irene, Martín Arranz Maria Dolores

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

INTRODUCTION

The dose of thiopurine drugs in combined treatments with anti-TNF in inflammatory bowel disease (IBD) has not been clearly established. The purpose of this study is to assess whether the dose of azathioprine influences clinical and biochemical response/remission rates, and anti-TNF drug levels/antibody formation.

MATERIAL AND

METHODS

Patients with IBD on combined maintenance treatment with azathioprine and infliximab or adalimumab were selected. Based on the dose of azathioprine, two groups were defined (standard: 2-2.5mg/kg/day; and decreased: less than 2mg/kg/day).

RESULTS

In the IFX group, there were no statistically significant differences (p=0.204) in the rates of remission (39% vs 41.3%), response (10% vs 21.7%) or failure (51.5% vs 37%) depending on the dose of thiopurine drugs. No differences were found between AZA-dose dependent IFX levels (2.46 vs 3.21μg/mL; p=0.211). In the adalimumab group, there were no statistically significant differences (p=0.83) in the rates of remission (66% vs 56%), response without remission (15.38% vs 25%) or failure (18% vs 18%) depending on the dose of thiopurines. With respect to ADA-levels, no differences were found in both groups (7.69 vs 8.23μg/mL; p=0.37).

CONCLUSION

In our experience, no statistically significant differences were found in either anti-TNF levels or clinical-biological response/remission rates based on doses of azathioprine.

Для цитирования: Lucas Ramos Javier, Suárez Ferrer Cristina, Poza Cordón Joaquín, Sánchez Azofra María, Rueda García Jose Luis, Martin Arranz Eduardo, Yebra Carmona Jorge, Andaluz García Irene, Martín Arranz Maria Dolores. Optimization of azathioprine dose in combined treatment with anti-TNF-alpha in inflammatory bowel disease.. Gastroenterologia y hepatologia. 2020. DOI: 10.1016/j.gastrohep.2020.10.004.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.